TABLE 2

Lesion-Based Comparison of 68Ga-DOTATATE PET, 68Ga-DOTANOC PET, and Conventional Imaging (CT, MR Imaging, or 18F-FDG PET/CT)

Tumor location/tumor typePatients*68Ga-DOTATATE lesions68Ga-DOTANOC lesionsP†CT, MR imaging, 18F-FDG PET/CT
Liver136888<0.00193
Lymph nodes739420.3643
Bone1089820.0289
Other organs1416200.2823
 Total182122320.005248
G1 GEP-NET443510.0252
G2 GEP-NET778810.5385
G3 GEP-NET7911000.12111
 Total182122320.005248

  • ↵* Number of patients in whom lesion analysis was available.

  • ↵† 68Ga-DOTATATE and 68Ga-DOTANOC were compared in lesion-by-lesion analysis using multivariate mixed-effects model.